# Microcap Mania: AI, Rockets, and Market Madness! Newsy: Bud Fox's 3 Controversial Stocks of the Day Published: 2026-06-12T14:01:00.433Z Source: https://newsyai.com/edition/905da28f-adc8-49e0-8594-c833f02fc32a Archive: https://newsyai.com/newsy/bde0e0f6-7fac-4abb-93a8-996b5464e3e9.md --- **Microcap Madness: BYAH's AI Skincare Rocket, SHAZ's NVIDIA Nut-Buster & the SpaceX Hangover Hype!**[[1]](https://stockanalysis.com/markets/premarket/gainers/) Futures are mixed into June 12, 2026—Dow flat to modestly up, Nasdaq showing lift amid Iran deal hopes, crude oil still flexing near recent highs. Microcap volatility rules the tape: low-float squeezes, partnership pumps, AI/data-center dildos, reverse-split scars, filing fumbles, dilution dick-punches, and the usual retail ape frenzy chasing any whiff of “AI/biotech/cloud” narrative. Today's stiffy showdown spotlights **BYAH** blasting off on a fresh AI skincare/health ecosystem deal, **SHAZ** ripping on a monster NVIDIA compute partnership, and **PWRL** (or similar SpaceX-linked plays) surging on the historic SPCX IPO debut. Bulls riding the green dildos; bears screaming “dilution rape, phantom contracts, and sub-penny doom ahead!” Let's dive balls-deep.[[2]](https://www.stocktitan.net/news/SHAZ/sharon-ai-announces-six-year-strategic-compute-collaboration-with-e2pvuxororjd.html) ### 1) Park Ha Biological Technology Co., Ltd. (BYAH): “AI Skincare Cock Rocket” vs. “Public Offering & Compliance Limp Dick” **Why it’s loud** **BYAH** detonated in premarket (+167%+ moves) amid insane volume on a strategic partnership with Star Plus Legend’s subsidiary to build an AI-powered skincare and health ecosystem (AI Nutritionist, store managers, skincare specialists). Tiny market cap (~$6M range), massive swings, history of $2.45M public offerings, compliance regains, and the eternal microcap governance red flags. Retail apes frothing over “AI wellness”; bears see equity fuckery and thin revenue.[[3]](https://finance.yahoo.com/quote/BYAH/) **Bull case (skincare stiffy supernova)** AI adjacency in booming wellness/cosmetics + partnership narrative = $10–25+ parabolic moonshot. Ape the digital health rocket! **Bear case (offering rape & compliance doom)** Chronic dilution risk from recent raises, thin fundamentals, past bid-price issues = sub-$1 bust. Short the limp dick before the next filing scare! **My take, first principles (real AI signal vs. capital-structure cancer)** Genuine partnership oxygen in a hot AI + consumer health niche provides short-term fuel, but repeated financings and microcap thinness highlight unsustainable structures. **Real narrative pump with real dilution risk.** Scalp the spunk? **$4–12**, **$8C** skincare stiffy—**P$2** fade. ### 2) SharonAI Holdings Inc. (SHAZ): “NVIDIA Compute Pecker” vs. “Financing Questions & Margin Squeeze Limp” **Why it’s loud** **SHAZ** surging (double-digit premarket pops) on a six-year strategic compute collaboration with NVIDIA for 72MW of new Australian data center capacity (up to 40,000 Grace Blackwell GPUs, revenue-sharing model, total capacity now 132MW). AI cloud hype meets execution questions from past short reports on “questionable financing” and phantom contracts. Retail chasing “Australia’s CoreWeave”; bears hammering revenue trajectory and governance.[[2]](https://www.stocktitan.net/news/SHAZ/sharon-ai-announces-six-year-strategic-compute-collaboration-with-e2pvuxororjd.html) **Bull case (AI factory cock rocket)** NVIDIA partnership tailwinds + massive GPU deployment = $15–40+ rebound. Ape the infrastructure revolution! **Bear case (financing rape & volatility doom)** Past short attacks, convertible note overhangs, margin/execution risks = sub-$5 crash. Short the limp before the next volume fade! **My take, first principles (real NVIDIA signal vs. operational fuckery)** Sector tailwinds in AI compute are legitimate, but historical scrutiny and microcap governance issues scream classic volatility trap. **Real partnership oxygen with real sustainability risk.** Scalp the spunk? **$8–20**, **$12C** AI stiffy—**P$5** fade. ### 3) Powerlaw (PWRL) / SpaceX-Linked Plays: “Starlink Holdings Stiffy” vs. “IPO Valuation Rape & Overhang Limp” **Why it’s loud** SpaceX’s record-breaking IPO (SPCX) launches today at ~$135/share targeting $1.77T valuation and $75B raise—the largest ever—sparking spillover surges in related holdings like PWRL. Retail frenzy on Musk ecosystem adjacency; bears cite analyst skepticism (some see fair value ~half the IPO price), massive dilution potential, and broader market rotation risks.[[4]](https://www.reuters.com/business/media-telecom/spacex-plans-raise-75-billion-ipo-135-per-share-source-says-2026-06-03/) **Bull case (space cock rocket)** Starlink/AI synergy + Musk halo = explosive upside. Ape the frontier! **Bear case (valuation rape & delisting doom)** Sky-high valuation debates, execution/governance risks in a new public entity = sharp post-IPO fade. Short the limp before reality bites! **My take, first principles (real space signal vs. capital-structure cancer)** Genuine technological and market momentum exists, but the massive raise, valuation split, and microcap spillover volatility highlight high-risk structures. **Real hype with real overvaluation risk.** Scalp the spunk? **Tactical ranges vary by ticker**—fade on weakness. **Tape-Side Tactics (BYAH Skincare Grab, SHAZ NVIDIA Pump & SpaceX Hangover Volatility)** - **BYAH**: **$4–12** skincare stiffy; **$8C** partnership pump, **P$2** dilution fade. - **SHAZ**: **$8–20** AI stiffy; **$12C** NVIDIA pump, **P$5** financing fade. - **PWRL/SpaceX plays**: Volatility scalps around IPO debut—**pump the news, fade the valuation debate**. Futures foreskin-flay amid crude cock-up and micro-madness. Balls-deep DYOR, NFA, degens duck the dilutions! **Sources** (for tracking every claim above): - Premarket movers & % changes: StockAnalysis, Benzinga, TradingView (June 12, 2026 data). - BYAH details (partnership, offerings, compliance): GlobeNewswire, Yahoo Finance, TipRanks (2026 updates). - SHAZ details (NVIDIA deal, capacity, past reports): Business Wire, Seeking Alpha, Barron’s (June 12, 2026 announcements). - SpaceX/PWRL context (IPO pricing, valuation debates): Reuters, CNBC, Bloomberg (June 2026 coverage). - Broader microcap context: MarketWatch, CME Group (June 2026).